Iterum Therapeutics announces $5M registered direct offering of ordinary shares and pre-funded warrants

Iterum Therapeutics plc

Gross proceeds of $5.0M from sale of 5,555,556 shares/warrants at $0.90 each.
Net proceeds ~$4.2M after fees; H.C. Wainwright acting as placement agent.
Funding to support pre-commercialization of ORLYNVAH and strategic process, cash runway into 2026.
Offering expected to close April 30, 2025, subject to customary conditions.
Pre-funded warrants exercisable at $0.01 per share with 9.99% beneficial ownership cap.

item 1.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-105148
form_type: 8-K
ticker: ITRMF
cik: 0001659323
company_name: Iterum Therapeutics plc
filed_at: 2025-04-30T23:59:59+00:00
discovered_at: 2026-05-14T18:02:49.236539+00:00
generated_at: 2026-05-23T02:24:39.870915+00:00
sec_items: ["1.01", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-105148
json_url: https://secwatch.observer/filing/0001193125-25-105148.json
markdown_url: https://secwatch.observer/filing/0001193125-25-105148.md
text_url: https://secwatch.observer/filing/0001193125-25-105148.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/0001193125-25-105148-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/d803323d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-105148

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.